Purchase Order HHSN272201401211P
Award Date
9/19/14
Potential Completion Date
10/19/14
Potential Value
$13K
Federal Agency
NIAID DEA OA Acquisitions
Awardee
Advanced Biotechnologies, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Columbia, MD 21046, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,469,410.09, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods and a leading contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The contract is for NIAID...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,920.00 firm fixed-price purchase order contract to ABI Scientific Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract was awarded on September 24, 2018, with a completion date of October 24, 2018, and the place of performance is Bethesda, Maryland. This contract does not have a set-aside designation.
This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), is valued at $79,489.53. The contract was awarded to the prime contractor, Advanced Bioscience Laboratories, Inc. (ABL), to assist NIAID in planning and implementing two consultations focused on quality management systems and quality risk management for NIAID contractors and extramural programmatic staff. The contract has no set-aside...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization. The $548,977.00 cost-plus-fixed-fee contract is for the delivery of services in support of NIAID's infectious disease research and product development initiatives. This award is a task order under an existing Indefinite...
This federal contract award of $9,360,216.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract supports NIAID's Preclinical Development program for the production of Current Good Manufacturing Practice (cGMP) native flexibly linked HIV-1 envelope protein. ABL has been awarded multiple Indefinite...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $795,403.00 contract is a delivery order awarded under an existing Indefinite Delivery Vehicle (IDV) for "Advanced Bioscience Laboratories Mucosal Vaccine Technologies". The contract is cost-plus-fixed-fee in type...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $174,091.42 cost-plus-fixed-fee contract is for planning and implementation of a NIAID consultation on advancing the development of multipurpose prevention technologies (MPTs). This is a delivery order issued under NIAID's HIV Microbicides and Biomedical Prevention 2016-2021 IDIQ...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $33,000 firm fixed price purchase order to ABI Scientific Inc. to provide cell growth enhancers and mediums. Under the contract, ABI Scientific will deliver ProBooster, CelBooster, and AbBooster products totaling 90 units to support NIAID's structural analysis, immunogen screening, and pre-clinical animal studies for vaccine development targeting HIV-1, SARS-CoV-2, and other viruses. The...
This federal contract award, valued at $572,349.48, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for material receipt, storage, shipping, and inventory services to support NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. This is a Delivery Order under ABL's existing...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $31,202.00 fixed-price level of effort contract is for process development of vaccine candidates, including for SARS-CoV-2. The award has an ultimate completion date of April 15, 2025. ABL has been awarded multiple indefinite...